What is the real cost of bevacizumab for patients with advanced bowel cancer?
Sue Ryder.
Lorraine
L
Dixon
D020533:Angiogenesis Inhibitors / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D003659:Decision Making, Organizational; D016527:Drug Costs; D006801:Humans; D010166:Palliative Care; D006113:United Kingdom
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab